Navigation Links
Covidien receives FDA clearance for its Puritan Bennett 840 ventilator system
Date:8/6/2009

Covidien (NYSE: COV), a leading global healthcare products company and recognized innovator in mechanical ventilation and respiratory care devices, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Leak Compensation software feature for the Puritan Bennett 840 ventilator system. This option provides continuous levels of mechanical ventilation to patients requiring respiratory support, regardless of the level of gas leakage that might occur in the circuit or past a patient interface device in the clinical setting.

During either invasive or noninvasive ventilation, air leaks past a mask, nasal prongs, nasal pillow, supraglottic airway, endotracheal tube or tracheostomy tube can result in loss of gas volume, potentially causing subsequent dysynchrony between a patient's spontaneous breathing efforts and the ventilator's response.

The Leak Compensation software for the Puritan Bennett 840 ventilator automatically adjusts for leaks of up to:

  • 10 liters per minute (lpm) for neonates with an ideal body weight as low as 0.5 kg
  • 40 lpm for pediatric patients
  • 65 lpm for adults

The Leak Compensation software also minimizes potential guesswork in determining the appropriate settings required to compensate for leakage.

"Gas leakage presents a challenge in high-leak environments, particularly during noninvasive ventilation where leaks associated with the use of masks, nasal prongs and nasal pillows frequently occur. These leaks can contribute to significant asynchrony between a patient and the ventilator, which in turn might impede weaning and increase the time that the patient is ventilator-dependent," said Roger S. Mecca, M.D., Vice President, Medical Affairs, Respiratory and Monitoring Solutions, Covidien. "Covidien now offers software that quickly adjusts for leakage, improving patient-ventilator synchrony and triggering. It is especially valuable for preventing auto-triggering when the leakage rate exceeds the flow-triggering threshold."

The Puritan Bennett 840 ventilator system with Leak Compensation software is available now and is intended for use in hospitals and similar medical care facilities. It may also be used during transport within such facilities if appropriate electrical power and compressed gas sources are available.

"This FDA 510(k) clearance allows Covidien to make respiratory therapists and nurses aware that new software for their Puritan Bennett 840 ventilator system is available for them to employ during care, ideally improving clinical outcomes," said Jim Willett, General Manager and Vice President, Airway and Ventilation, Respiratory and Monitoring Solutions, Covidien.


'/>"/>

Contact: Katherine Tripple
ktripple@fkhealth.com
617-761-6723
Feinstein Kean Healthcare
Source:Eurekalert

Related medicine news :

1. Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien
2. Nuvo Research and Covidien sign U.S. license and development agreement for Pennsaid(R) and Pennsaid Plus(R)
3. Covidien announces milestone placement in remote respiratory monitoring
4. BullMarket.com Examines Healthcare Stocks: Psych Solutions, Cerner, Aetna, Covidien and HCP
5. Covidien Canada Streamlines Integration and Processing of Fax-based Orders With GHX G-Fax(TM) Fax Conversion Service
6. Rochester Medical Announces Settlement With TYCO Healthcare Group, L.P., Now Operating as Covidien Ltd.
7. Covidien Launches First-In-Class, Questra-Based Valleylab(TM) Exchange Software Update System
8. Orphanage Receives Nearly $1 Million from Private Donor
9. Chesson Labs Liquid Bandage Product NUVADERM(TM) Receives FDA 510(k) Market Clearance
10. AccuVein Vein Illuminator Receives European CE Mark
11. CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... ... Pink , a national non-profit organization focusing on the prevention and early detection of breast ... proud to announce Katie Thiede as their new Chief Executive Officer. In January, founder Lindsay ... the Board and launched a national search to find a visionary new leader to grow ...
(Date:4/24/2017)... ... April 24, 2017 , ... ALP ... food supplements, announced its popular products are now available for purchase on StackedNutrition.com, ... prioritizes the use of premium natural ingredients in making all of its products. ...
(Date:4/24/2017)... NEW PORT RICHEY, Fla. (PRWEB) , ... April ... ... Disease Control and Prevention (CDC), rising prescription opioid overdose deaths now claim the ... (DEA) has slashed its civil case filings against drug manufacturers, distributors, pharmacies and ...
(Date:4/24/2017)... ... 2017 , ... As a former supermodel known for her timeless beauty, Joan ... single women is that she put all the words in her new book, "Manifest ... personal experiences and sparkling sense of humor have inspired her to write a book ...
(Date:4/24/2017)... ... ... “Reflections of God’s Work”: an enlightening collection of life lessons leading each ... published author, Jerri Broglin, a survivor of great loss who gained insight on how ... for those searching for answers, as we are finding the answers that are so ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE ... Bloom Burton & Co. Healthcare Investor Conference 2017 at the Sheraton ... Edward Wright , Chief Executive Officer of the Company is scheduled ... CFO, Richard Bear and the Chairman of the Board, ... ...
(Date:4/19/2017)... Global Surgical Drainage Device Market: Overview ... remove excess liquid and air. The fluid to be ... lymph. Surgical drains are used in a wide variety ... cardiovascular surgery, neurosurgery, plastic surgery etc. Common use of ... of fluid e.g. blood or pus. Surgical drains are ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
Breaking Medicine Technology: